Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Optiscan Imaging Limited (DE:O5S)
BERLIN:O5S
Holding DE:O5S?
Track your performance easily
O5S Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.04 - €0.14
Previous Close€0.09
Volume0.00
Average Volume (3M)N/A
Market Cap
€86.41M
Enterprise Value€84.00M
Total Cash (Recent Filing)AU$4.53M
Total Debt (Recent Filing)AU$548.67K
Price to Earnings (P/E)―
Beta0.50
Next Earnings
Mar 03, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.24
R-Squared0.06
Alpha0.00231
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)65.24
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Optiscan Imaging Limited News
PremiumCompany Announcements
Optiscan and Monash University Partner for AI-Powered GI EndoscopePremiumCompany Announcements
Optiscan Imaging Reports Strong Growth and Strategic Advances
PremiumCompany Announcements
Optiscan Imaging Expands US Market Presence Through Key Events
PremiumCompany Announcements
Optiscan Imaging’s 2024 AGM: In-Person and Virtual
PremiumCompany Announcements
Optiscan Imaging Sets Date for Annual Meeting
PremiumCompany Announcements
Optiscan Imaging Upholds Corporate Governance Standards
PremiumCompany Announcements
Optiscan Imaging Faces Revenue Decline, Focuses on Growth
PremiumCompany Announcements
Optiscan Partners to Revolutionize Veterinary Cancer CareO5S FAQ
What was Optiscan Imaging Limited’s price range in the past 12 months?
Optiscan Imaging Limited lowest stock price was €0.04 and its highest was €0.14 in the past 12 months.
What is Optiscan Imaging Limited’s market cap?
Currently, no data Available
When is Optiscan Imaging Limited’s upcoming earnings report date?
Optiscan Imaging Limited’s upcoming earnings report date is Mar 03, 2025 which is in 113 days.
How were Optiscan Imaging Limited’s earnings last quarter?
Optiscan Imaging Limited released its earnings results on Aug 30, 2024. The company reported -€0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.002.
Is Optiscan Imaging Limited overvalued?
According to Wall Street analysts Optiscan Imaging Limited’s price is currently Overvalued.
Does Optiscan Imaging Limited pay dividends?
Optiscan Imaging Limited does not currently pay dividends.
What is Optiscan Imaging Limited’s EPS estimate?
Optiscan Imaging Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Optiscan Imaging Limited have?
Optiscan Imaging Limited has 835,340,800 shares outstanding.
What happened to Optiscan Imaging Limited’s price movement after its last earnings report?
Optiscan Imaging Limited reported an EPS of -€0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Optiscan Imaging Limited?
Currently, no hedge funds are holding shares in DE:O5S
---
Optiscan Imaging Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
DE:O5S Sentiment 88%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-71.67%
Trailing 12-Months
Asset Growth
234.55%
Trailing 12-Months
Company Description
Optiscan Imaging Limited
Optiscan Imaging Ltd is an Australian company that developed and patented miniaturised confocal microscopes. The company products include Optiscan FIVE1 and Pentax ICS-1000 platforms a miniaturised fluorescence endomicroscope platform that brings the next generation of Optiscan's incredible imaging capability and flexibility to Preclinical Research.
---
Technical Analysis
---